Admire Chikandiwa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Admire Chikandiwa has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Sinead Delany-Moretlwe
Wits RHI, University of the Witwatersrand , Johannesburg
6 shared publications - Matthew Francis Chersich
Wits Planetary Health Research Division, Faculty of Health Sciences, University of Witwatersrand
4 shared publications Philippe Mayaud
Affiliation London School of Hygiene & Tropical Medicine, London, United Kingdom
4 shared publicationsSinead Delany-Moretlwe
Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
4 shared publicationsPedro T. Pisa
Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, 22 Esselen Street, Hillbrow, Johannesburg, 2001, South Africa
3 shared publications- Philippe Mayaud
Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom
3 shared publications
Latest Publications
- Open Access
Engaging adolescent girls and young women in HIV prevention: A retrospective, observational outcome evaluation of the Eyakho Mo’ghel digital rewards programme in South Africa
: Introduction: Adolescent girls and young women (AGYW) in South Africa face disproportionately high HIV incidence, yet uptake and retention in prevention services remain suboptimal. Behavioural economics approaches, including incentive-based models, have shown promise in improving health-seeking behaviours among this population. This study evaluated the Eyakho Mo’ghel (EM) programme, a membership-based digital rewards initiative implemented by Shout-It-Now within the DREAMS HIV prevention framework, to assess its impact on HIV prevention and sexual and reproductive health (SRH) service engagement among AGYW. Methods: A retrospective, observational outcome evaluation was conducted across the full programme implementation period (December 2021–February 2025) in five districts in Gauteng and North West provinces, South Africa. Deidentified clinical and app records for 4,684 EM members were analysed alongside a 1:1 matched comparison group of 4,684 non-members drawn from approximately one million records using stratified random sampling. Outcomes included HIV testing, pre-exposure prophylaxis (PrEP) uptake and persistence, contraceptive use, gender-based violence (GBV) disclosure, and key health indicators. Multivariable logistic and Poisson regression models, adjusted for age and district, were used to examine associations between EM membership, app usage patterns, and outcomes. Results: EM members were over three times more likely to have tested for HIV (OR = 3.16, 95% CI: 2.83–3.54) and tested significantly more frequently than non-members. PrEP initiation was also markedly higher among EM members (OR = 3.15, 95% CI: 2.85–3.48), and persistence beyond the first dispensation was approximately 67% more likely (OR = 1.67, 95% CI: 1.63–1.72). Contraceptive uptake was 75% more likely (OR = 1.75, 95% CI: 1.53–2.01), and EM members were 54% more likely to disclose GBV experiences (OR = 1.54, 95% CI: 1.24–1.91). Sustained app engagement and cumulative point accumulation were consistently associated with improved outcomes. No significant differences in HIV seroconversion, TB screening, or incident pregnancy were observed. Conclusions: A non-monetary, digitally integrated rewards programme was associated with meaningful improvements in HIV prevention service uptake, PrEP persistence, contraceptive use, and GBV disclosure among AGYW. These findings support the integration of incentive-based digital engagement models within combination HIV prevention frameworks, particularly in resource-constrained settings.
Open AccessEngaging adolescent girls and young women in HIV prevention: A retrospective, observational outcome evaluation of the Eyakho Mo’ghel digital rewards programme in South Africa
: Introduction: Adolescent girls and young women (AGYW) in South Africa face disproportionately high HIV incidence, yet uptake and retention in prevention services remain suboptimal. Behavioural economics approaches, including incentive-based models, have shown promise in improving health-seeking behaviours among this population. This study evaluated the Eyakho Mo’ghel (EM) programme, a membership-based digital rewards initiative implemented by Shout-It-Now within the DREAMS HIV prevention framework, to assess its impact on HIV prevention and sexual and reproductive health (SRH) service engagement among AGYW. Methods: A retrospective, observational outcome evaluation was conducted across the full programme implementation period (December 2021–February 2025) in five districts in Gauteng and North West provinces, South Africa. Deidentified clinical and app records for 4,684 EM members were analysed alongside a 1:1 matched comparison group of 4,684 non-members drawn from approximately one million records using stratified random sampling. Outcomes included HIV testing, pre-exposure prophylaxis (PrEP) uptake and persistence, contraceptive use, gender-based violence (GBV) disclosure, and key health indicators. Multivariable logistic and Poisson regression models, adjusted for age and district, were used to examine associations between EM membership, app usage patterns, and outcomes. Results: EM members were over three times more likely to have tested for HIV (OR = 3.16, 95% CI: 2.83–3.54) and tested significantly more frequently than non-members. PrEP initiation was also markedly higher among EM members (OR = 3.15, 95% CI: 2.85–3.48), and persistence beyond the first dispensation was approximately 67% more likely (OR = 1.67, 95% CI: 1.63–1.72). Contraceptive uptake was 75% more likely (OR = 1.75, 95% CI: 1.53–2.01), and EM members were 54% more likely to disclose GBV experiences (OR = 1.54, 95% CI: 1.24–1.91). Sustained app engagement and cumulative point accumulation were consistently associated with improved outcomes. No significant differences in HIV seroconversion, TB screening, or incident pregnancy were observed. Conclusions: A non-monetary, digitally integrated rewards programme was associated with meaningful improvements in HIV prevention service uptake, PrEP persistence, contraceptive use, and GBV disclosure among AGYW. These findings support the integration of incentive-based digital engagement models within combination HIV prevention frameworks, particularly in resource-constrained settings.
- Open Access
- 19 April 2026
- Published by Elsevier in SSRN Electronic Journal
From Pills to Injections: Youth Preferences, Barriers, and Service Pathways for Long-Acting PrEP in South Africa
Background: South Africa remains the epicentre of the HIV epidemic, with adolescent girls and young women (AGYW) disproportionately affected. While oral PrEP is effective, uptake and adherence among AGYW remains suboptimal, underscoring the need for acceptable and broader choice options including long-acting PrEP (LAP) options. We sought implementation-focused evidence to inform youth-centred, differentiated PrEP and LAP delivery models to support national HIV prevention scale-up.Methods: We conducted an exploratory mixed-methods implementation study integrating data from a systematic literature review, routine oral PrEP programme data (n=97 138), an AGYW cross-sectional survey (n=189), and focus group discussions (n=35). Quantitative data was analysed using descriptive and multivariable methods. Qualitative data underwent thematic analysis. Findings were triangulated to map enablers, barriers, and delivery preferences.Findings: LAP was the most attractive HIV prevention modality among survey participants (71%). Motivations centred on convenience, discretion, and reduced adherence burden. Survival analysis of programme data revealed sharp attrition immediately following oral PrEP initiation, particularly within the first 12 weeks. Among those who remained on PrEP (n = 80 928), about 81% (65 551/80 928) would remain on PrEP for at least 5 years. Most study participants learned about PrEP via school programmes (42%) or mobile clinics (35%), with smaller roles for social media (16%) and peers (13%), while most trusted nurses for PrEP information (81%). They were motivated to use PrEP due to HIV risk (73%) and partner infidelity concerns (84%), felt empowered (91%) and valued reminders (88%). Barriers included fear of judgment (73%), safety concerns (54%), stigma (53%), inconvenient clinic hours (47%), forgetting daily pills (42%), limited-service access (25%), and side effects (22%).Interpretation: Demand for LAP among AGYW is high, driven by convenience, privacy, and empowerment. However, early discontinuation, stigma, and access barriers persist. Scaling up LAP requires youth-centred delivery innovations, accessible service models, stigma-free environments, and trusted communication strategies to maximize impact.
- 19 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessFrom Pills to Injections: Youth Preferences, Barriers, and Service Pathways for Long-Acting PrEP in South Africa
Background: South Africa remains the epicentre of the HIV epidemic, with adolescent girls and young women (AGYW) disproportionately affected. While oral PrEP is effective, uptake and adherence among AGYW remains suboptimal, underscoring the need for acceptable and broader choice options including long-acting PrEP (LAP) options. We sought implementation-focused evidence to inform youth-centred, differentiated PrEP and LAP delivery models to support national HIV prevention scale-up.Methods: We conducted an exploratory mixed-methods implementation study integrating data from a systematic literature review, routine oral PrEP programme data (n=97 138), an AGYW cross-sectional survey (n=189), and focus group discussions (n=35). Quantitative data was analysed using descriptive and multivariable methods. Qualitative data underwent thematic analysis. Findings were triangulated to map enablers, barriers, and delivery preferences.Findings: LAP was the most attractive HIV prevention modality among survey participants (71%). Motivations centred on convenience, discretion, and reduced adherence burden. Survival analysis of programme data revealed sharp attrition immediately following oral PrEP initiation, particularly within the first 12 weeks. Among those who remained on PrEP (n = 80 928), about 81% (65 551/80 928) would remain on PrEP for at least 5 years. Most study participants learned about PrEP via school programmes (42%) or mobile clinics (35%), with smaller roles for social media (16%) and peers (13%), while most trusted nurses for PrEP information (81%). They were motivated to use PrEP due to HIV risk (73%) and partner infidelity concerns (84%), felt empowered (91%) and valued reminders (88%). Barriers included fear of judgment (73%), safety concerns (54%), stigma (53%), inconvenient clinic hours (47%), forgetting daily pills (42%), limited-service access (25%), and side effects (22%).Interpretation: Demand for LAP among AGYW is high, driven by convenience, privacy, and empowerment. However, early discontinuation, stigma, and access barriers persist. Scaling up LAP requires youth-centred delivery innovations, accessible service models, stigma-free environments, and trusted communication strategies to maximize impact.
- Open Access
- 13 January 2026
- Published by Elsevier in SSRN Electronic Journal
Vaccine Acceptance and Hesitancy in a Single-Dose HPV Vaccination Campaign in South Africa: A Qualitative Study Among Diverse Stakeholders
Primary prevention of HPV through vaccination of girls is central to effective control of cervical cancer and to achieving the new global goal of elimination. In South Africa’s school-based national HPV vaccination programme, coverage of both one and two doses of the bivalent vaccine has declined since its inception in 2014. Qualitative data on vaccine-decision making and vaccine hesitancy were collected alongside a study on the impact of a single-dose HPV vaccination schedule in one district of the Free State province, South Africa. Individual in-depth interviews were held with vaccine-eligible girls aged ≥15 years and their caregivers. In-depth key informant (KI) interviews were held with teachers, health and education ministry officials, and nurses who implemented the single-dose campaign. Twenty-one participants were interviewed, including six caregivers, six learners (one not vaccinated), and nine KIs. Caregivers consulted widely in vaccine decision-making, often with healthcare workers (HCW), and many sourced vaccine information on the internet. Learners frequently sought to convince their caregivers of the merits of vaccination. Fear of cancer was a strong motivator for vaccine acceptance, while vaccine hesitancy was mainly driven by fears of the vaccine causing serious side effects, infertility, or cancer. Learners queried the vaccine’s impact on their sexual and reproductive health (SRH) and black caregivers voiced suspicion of a racial bias in campaign targeting. Non-return of informed consent forms may reflect both administrative errors and potential vaccine refusal. The study highlights the need for HPV vaccine hesitancy in this setting to be explicitly addressed in future sensitization and advocacy activities.
- 13 January 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessVaccine Acceptance and Hesitancy in a Single-Dose HPV Vaccination Campaign in South Africa: A Qualitative Study Among Diverse Stakeholders
Primary prevention of HPV through vaccination of girls is central to effective control of cervical cancer and to achieving the new global goal of elimination. In South Africa’s school-based national HPV vaccination programme, coverage of both one and two doses of the bivalent vaccine has declined since its inception in 2014. Qualitative data on vaccine-decision making and vaccine hesitancy were collected alongside a study on the impact of a single-dose HPV vaccination schedule in one district of the Free State province, South Africa. Individual in-depth interviews were held with vaccine-eligible girls aged ≥15 years and their caregivers. In-depth key informant (KI) interviews were held with teachers, health and education ministry officials, and nurses who implemented the single-dose campaign. Twenty-one participants were interviewed, including six caregivers, six learners (one not vaccinated), and nine KIs. Caregivers consulted widely in vaccine decision-making, often with healthcare workers (HCW), and many sourced vaccine information on the internet. Learners frequently sought to convince their caregivers of the merits of vaccination. Fear of cancer was a strong motivator for vaccine acceptance, while vaccine hesitancy was mainly driven by fears of the vaccine causing serious side effects, infertility, or cancer. Learners queried the vaccine’s impact on their sexual and reproductive health (SRH) and black caregivers voiced suspicion of a racial bias in campaign targeting. Non-return of informed consent forms may reflect both administrative errors and potential vaccine refusal. The study highlights the need for HPV vaccine hesitancy in this setting to be explicitly addressed in future sensitization and advocacy activities.
- Open Access
- 6 January 2025
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 3 (1) , 7
Outcomes of hysterectomy for puerperal sepsis at an Academic Hospital: A retrospective study
Background: Pregnancy-related sepsis contributes significantly to maternal mortality. While there is substantial information on postpartum hysterectomy, information on outcomes of hysterectomy as source control for puerperal sepsis is limited. Knowledge of the common causative organisms and their antimicrobial sensitivity may assist with targeted antibiotic therapy to improve patient outcomes. This study described the indications and outcomes of surgery in patients following hysterectomy as source control for puerperal sepsis.Methods: In a retrospective study, we analysed the intra-operative and histological findings and the results of microbial culture and antibiotic sensitivity of women who underwent a hysterectomy for puerperal sepsis at Chris Hani Baragwanath Academic Hospital (CHBAH), Johannesburg, from January 2019 to December 2019.Results: Twenty-nine (88%) of the 33 women with hysterectomy for puerperal sepsis studied had a caesarean section (CS), 14 (48%) of whom had a CS performed for foetal distress. Eight of these 33 women (24%) had hypertensive-related disorders. The most common organisms cultured in the intra-abdominal fluid were Acinetobacter baumannii (n = 11, 26%), E. coli (n = 8, 19%), Klebsiella species (n = 6, 14%) and Enterococcus faecalis (n = 6, 14%) of a total of 42 organisms were identified from all sites. Puerperal sepsis was confirmed in 28 (85%) of the uterine histology samples, with a mortality rate of 6% in this study.Conclusion: Hysterectomy for puerperal sepsis was most frequently associated with CS, with hypertensive-related disorders the most common indication. Histological confirmation of sepsis is required, as the histological findings differed by 15% with surgical diagnosis.Contribution: A. baumannii was the most common species isolated as the cause of infection.
- 6 January 2025
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 3 (1) , 7
Open AccessOutcomes of hysterectomy for puerperal sepsis at an Academic Hospital: A retrospective study
Background: Pregnancy-related sepsis contributes significantly to maternal mortality. While there is substantial information on postpartum hysterectomy, information on outcomes of hysterectomy as source control for puerperal sepsis is limited. Knowledge of the common causative organisms and their antimicrobial sensitivity may assist with targeted antibiotic therapy to improve patient outcomes. This study described the indications and outcomes of surgery in patients following hysterectomy as source control for puerperal sepsis.Methods: In a retrospective study, we analysed the intra-operative and histological findings and the results of microbial culture and antibiotic sensitivity of women who underwent a hysterectomy for puerperal sepsis at Chris Hani Baragwanath Academic Hospital (CHBAH), Johannesburg, from January 2019 to December 2019.Results: Twenty-nine (88%) of the 33 women with hysterectomy for puerperal sepsis studied had a caesarean section (CS), 14 (48%) of whom had a CS performed for foetal distress. Eight of these 33 women (24%) had hypertensive-related disorders. The most common organisms cultured in the intra-abdominal fluid were Acinetobacter baumannii (n = 11, 26%), E. coli (n = 8, 19%), Klebsiella species (n = 6, 14%) and Enterococcus faecalis (n = 6, 14%) of a total of 42 organisms were identified from all sites. Puerperal sepsis was confirmed in 28 (85%) of the uterine histology samples, with a mortality rate of 6% in this study.Conclusion: Hysterectomy for puerperal sepsis was most frequently associated with CS, with hypertensive-related disorders the most common indication. Histological confirmation of sepsis is required, as the histological findings differed by 15% with surgical diagnosis.Contribution: A. baumannii was the most common species isolated as the cause of infection.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 3 (1) , 6
The predictive value of risk assessment models for venous thromboembolism on gynaecological cancer patients
Background: Venous thromboembolism (VTE) is a multifactorial disease. There are two main clinical entities that are associated with morbidity and mortality, deep vein thrombosis and pulmonary embolism. Our study aimed to compare the three risk assessment models (RAMs), Khorana, Caprini and Padua in terms of predicting VTE in gynaecologic oncology patients. Methods: Patients were retrospectively scored according to Caprini, Padua and Khorana scoring models to assess the risk for VTE. Accuracy analysis of risk assessment models was performed using sensitivity, specificity, positive and negative predictive values as well as the area under the curve of each model per patient. Results: The Caprini score has good sensitivity (80.0), a poor specificity (24.3), low positive predictive value (7.2) and good negative predictive value (94.3) (95% CI). The Khorana score has a poor sensitivity (30.0), a fair specificity (62.5), low positive predictive value (5.6) and good negative predictive value (92.4) (95% CI). The Padua score has an average sensitivity (60.0), a poor specificity (42.6), low positive predictive value (7.1) and good negative predictive value (93.5) (95% CI). The Caprini score had the overall best performance. Conclusion: Caprini score performed better and proved to be the best score. It has the potential to reduce mortality associated with VTE in gynaecological cancer patients. However, the Caprini score needs to be tested in the same population in a prospective study in a multicentre. Contribution: The results of this study prove to us that Caprini score is the best to be used in a South African setting.
- 1 January 2025
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 3 (1) , 6
Open AccessThe predictive value of risk assessment models for venous thromboembolism on gynaecological cancer patients
Background: Venous thromboembolism (VTE) is a multifactorial disease. There are two main clinical entities that are associated with morbidity and mortality, deep vein thrombosis and pulmonary embolism. Our study aimed to compare the three risk assessment models (RAMs), Khorana, Caprini and Padua in terms of predicting VTE in gynaecologic oncology patients. Methods: Patients were retrospectively scored according to Caprini, Padua and Khorana scoring models to assess the risk for VTE. Accuracy analysis of risk assessment models was performed using sensitivity, specificity, positive and negative predictive values as well as the area under the curve of each model per patient. Results: The Caprini score has good sensitivity (80.0), a poor specificity (24.3), low positive predictive value (7.2) and good negative predictive value (94.3) (95% CI). The Khorana score has a poor sensitivity (30.0), a fair specificity (62.5), low positive predictive value (5.6) and good negative predictive value (92.4) (95% CI). The Padua score has an average sensitivity (60.0), a poor specificity (42.6), low positive predictive value (7.1) and good negative predictive value (93.5) (95% CI). The Caprini score had the overall best performance. Conclusion: Caprini score performed better and proved to be the best score. It has the potential to reduce mortality associated with VTE in gynaecological cancer patients. However, the Caprini score needs to be tested in the same population in a prospective study in a multicentre. Contribution: The results of this study prove to us that Caprini score is the best to be used in a South African setting.
- Top Cited PapersOpen Access
- 5 November 2024
- Published by Springer Nature in Nature Medicine
- Vol. 31 (2) , 684-694
A systematic review and meta-analysis of heat exposure impacts on maternal, fetal and neonatal health
Climate change has severe and wide-ranging health impacts, especially for vulnerable groups. Despite growing evidence of heat-associated adverse maternal and neonatal health outcomes, there remains a lack of synthesis quantifying associations and identifying specific risk periods. We systematically reviewed the literature on heat impacts on maternal, fetal and neonatal health and quantified impacts through meta-analyses. We found 198 studies across 66 countries, predominantly high income (63.3%) and temperate climate zones (40.1%), and 23 outcomes. Results showed increased odds of preterm birth of 1.04 (95% confidence interval (CI) = 1.03, 1.06; n = 12) per 1 °C increase in heat exposure and 1.26 (95% CI = 1.08, 1.47; n = 10) during heat waves. Similarly, high heat exposure increased the risk for stillbirths (odds ratio (OR) = 1.13 (95% CI = 0.95, 1.34; n = 9)), congenital anomalies (OR = 1.48 (95% CI = 1.16, 1.88; n = 6)) and gestational diabetes mellitus (OR = 1.28 (95% CI = 1.05, 1.74; n = 4)). The odds of any obstetric complication increased by 1.25 (95% CI = 1.09, 1.42; n = 11) during heat waves. Patterns in susceptibility windows varied by condition. The findings were limited by heterogeneity in exposure metrics and study designs. The systematic review demonstrated that escalating heat exposure poses a major threat to maternal and neonatal health, highlighting research priorities, guiding the selection and monitoring of heat-health indicators and emphasizing the need to prioritize maternal and neonatal health in national climate health programs.
- 5 November 2024
- Published by Springer Nature in Nature Medicine
- Vol. 31 (2) , 684-694
Top Cited PapersOpen AccessA systematic review and meta-analysis of heat exposure impacts on maternal, fetal and neonatal health
Climate change has severe and wide-ranging health impacts, especially for vulnerable groups. Despite growing evidence of heat-associated adverse maternal and neonatal health outcomes, there remains a lack of synthesis quantifying associations and identifying specific risk periods. We systematically reviewed the literature on heat impacts on maternal, fetal and neonatal health and quantified impacts through meta-analyses. We found 198 studies across 66 countries, predominantly high income (63.3%) and temperate climate zones (40.1%), and 23 outcomes. Results showed increased odds of preterm birth of 1.04 (95% confidence interval (CI) = 1.03, 1.06; n = 12) per 1 °C increase in heat exposure and 1.26 (95% CI = 1.08, 1.47; n = 10) during heat waves. Similarly, high heat exposure increased the risk for stillbirths (odds ratio (OR) = 1.13 (95% CI = 0.95, 1.34; n = 9)), congenital anomalies (OR = 1.48 (95% CI = 1.16, 1.88; n = 6)) and gestational diabetes mellitus (OR = 1.28 (95% CI = 1.05, 1.74; n = 4)). The odds of any obstetric complication increased by 1.25 (95% CI = 1.09, 1.42; n = 11) during heat waves. Patterns in susceptibility windows varied by condition. The findings were limited by heterogeneity in exposure metrics and study designs. The systematic review demonstrated that escalating heat exposure poses a major threat to maternal and neonatal health, highlighting research priorities, guiding the selection and monitoring of heat-health indicators and emphasizing the need to prioritize maternal and neonatal health in national climate health programs.
- Open Access
- 20 September 2024
- Published by Wiley in Reproductive, Female and Child Health
- Vol. 3 (3)
Causes and obstetric factors associated with timing of neonatal deaths in Soweto, South Africa
Objective: Describe characteristics of women whose decedents died during the neonatal period and explore factors associated with postnatal age at time of death.Methods: Analysis of data collected at the Child Health and Mortality Prevention Surveillance (CHAMPS) South Africa study site. CHAMPS generates cause of death data in children across nine sites in low‐ and middle‐income countries. Postnatal age at time of neonatal death was evaluated by Kaplan–Meier methods. Factors associated with time to neonatal death were evaluated using Cox proportional hazards regression models. Analyses were conducted in Stata 15.0®. p < 0.05 was considered statistically significant.Results: There were 225 neonatal deaths during the study period, of which 197 (87.5%) had data for mother‐neonate pairs, with 184 (81.7%) neonates having complete data. The median (IQR) maternal age at booking was 27 (23–34) years. Majority (72.3%, 142/197) of women were unmarried, unemployed (76.0%, 149/197) and were booked (85.0%, 141/166). There were 19.5% of women who had hypertensive disorders of pregnancy (HDP, 36/184) while 2.7% (5/184) had diabetes mellitus and 31.5% (58/184) were HIV positive. Most were early neonatal deaths (ENND; 79.4%, 146/184) and remainder (20.6%, 38/184) late neonatal deaths (LNND). The main underlying causes of death were prematurity (60.3%, 111/184), intrapartum hypoxia (17.4%, 32/184), neonatal sepsis (10.3%, 19/184) and congenital anomalies (9.2%, 17/184). Intrapartum hypoxia (Adjusted Hazard Ratio [aHR] = 2.01, 95% CI: 1.23–3.27, p = 0.01), assisted‐vaginal delivery compared to normal vaginal delivery (aHR = 1.96, 95% CI: 1.03–3.71, p = 0.04), preterm delivery (aHR = 1.62, 95% CI: 1.03–2, p = 0.04), Apgar score p = 0.02) and a previous neonatal death ([aHR] = 1.33; 95% CI: 1.10–1.89, p = 0.04) were associated with earlier time to neonatal death.Conclusion: Intrapartum complications were associated with earlier time to neonatal death. Improving intrapartum care can reduce neonatal deaths.
- 20 September 2024
- Published by Wiley in Reproductive, Female and Child Health
- Vol. 3 (3)
Open AccessCauses and obstetric factors associated with timing of neonatal deaths in Soweto, South Africa
Objective: Describe characteristics of women whose decedents died during the neonatal period and explore factors associated with postnatal age at time of death.Methods: Analysis of data collected at the Child Health and Mortality Prevention Surveillance (CHAMPS) South Africa study site. CHAMPS generates cause of death data in children across nine sites in low‐ and middle‐income countries. Postnatal age at time of neonatal death was evaluated by Kaplan–Meier methods. Factors associated with time to neonatal death were evaluated using Cox proportional hazards regression models. Analyses were conducted in Stata 15.0®. p < 0.05 was considered statistically significant.Results: There were 225 neonatal deaths during the study period, of which 197 (87.5%) had data for mother‐neonate pairs, with 184 (81.7%) neonates having complete data. The median (IQR) maternal age at booking was 27 (23–34) years. Majority (72.3%, 142/197) of women were unmarried, unemployed (76.0%, 149/197) and were booked (85.0%, 141/166). There were 19.5% of women who had hypertensive disorders of pregnancy (HDP, 36/184) while 2.7% (5/184) had diabetes mellitus and 31.5% (58/184) were HIV positive. Most were early neonatal deaths (ENND; 79.4%, 146/184) and remainder (20.6%, 38/184) late neonatal deaths (LNND). The main underlying causes of death were prematurity (60.3%, 111/184), intrapartum hypoxia (17.4%, 32/184), neonatal sepsis (10.3%, 19/184) and congenital anomalies (9.2%, 17/184). Intrapartum hypoxia (Adjusted Hazard Ratio [aHR] = 2.01, 95% CI: 1.23–3.27, p = 0.01), assisted‐vaginal delivery compared to normal vaginal delivery (aHR = 1.96, 95% CI: 1.03–3.71, p = 0.04), preterm delivery (aHR = 1.62, 95% CI: 1.03–2, p = 0.04), Apgar score p = 0.02) and a previous neonatal death ([aHR] = 1.33; 95% CI: 1.10–1.89, p = 0.04) were associated with earlier time to neonatal death.Conclusion: Intrapartum complications were associated with earlier time to neonatal death. Improving intrapartum care can reduce neonatal deaths.
- Open Access
- 10 June 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0252863
Experiences of doctoral students enrolled in a research fellowship program to support doctoral training in Africa (2014 to 2018): The Consortium for Advanced Research Training in Africa odyssey
Background: The Consortium for Advanced Research Training in Africa (CARTA) aims to transform higher education in Africa. One of its main thrusts is supporting promising university faculty (fellows) to obtain high quality doctoral training. CARTA offers fellows robust support which includes funding of their attendance at Joint Advanced Seminars (JASes) throughout the doctoral training period. An evaluation is critical in improving program outcomes. In this study; we, CARTA fellows who attended the fourth JAS in 2018, appraised the CARTA program from our perspective, specifically focusing on the organization of the program and its influence on the fellows’ individual and institutional development.Methods: Exploratory Qualitative Study Design was used and data was obtained from three focus group discussions among the fellows in March 2018. The data were analyzed using thematic approach within the framework of good practice elements in doctoral training–Formal Research Training, Activities Driven by Doctoral Candidates, Career Development as well as Concepts and Structures.Results: In all, 21 fellows from six African countries participated and all had been in the CARTA program for at least three years. The fellowship has increased fellows research skills and expanded our research capacities. This tremendously improved the quality of our doctoral research and it was also evident in our research outputs, including the number of peer-reviewed publications. The CARTA experience inculcated a multidisciplinary approach to our research and enabled significant improvement in our organizational, teaching, and leadership skills. All these were achieved through the well-organized structures of CARTA and these have transformed us to change agents who are already taking on research and administrative responsibilities in our various home institutions. Unfortunately, during the long break between the second and the third JAS, there was a gap in communication between CARTA and her fellows, which resulted in some transient loss of focus by a few fellows.Conclusion: The CARTA model which builds the research capacity of doctoral fellows through robust support, including intermittent strategic Joint Advanced Seminars has had effective and transformative impacts on our doctoral odyssey. However, there is a need to maintain the momentum through continuous communication between CARTA and the fellows all through this journey.
- 10 June 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0252863
Open AccessExperiences of doctoral students enrolled in a research fellowship program to support doctoral training in Africa (2014 to 2018): The Consortium for Advanced Research Training in Africa odyssey
Background: The Consortium for Advanced Research Training in Africa (CARTA) aims to transform higher education in Africa. One of its main thrusts is supporting promising university faculty (fellows) to obtain high quality doctoral training. CARTA offers fellows robust support which includes funding of their attendance at Joint Advanced Seminars (JASes) throughout the doctoral training period. An evaluation is critical in improving program outcomes. In this study; we, CARTA fellows who attended the fourth JAS in 2018, appraised the CARTA program from our perspective, specifically focusing on the organization of the program and its influence on the fellows’ individual and institutional development.Methods: Exploratory Qualitative Study Design was used and data was obtained from three focus group discussions among the fellows in March 2018. The data were analyzed using thematic approach within the framework of good practice elements in doctoral training–Formal Research Training, Activities Driven by Doctoral Candidates, Career Development as well as Concepts and Structures.Results: In all, 21 fellows from six African countries participated and all had been in the CARTA program for at least three years. The fellowship has increased fellows research skills and expanded our research capacities. This tremendously improved the quality of our doctoral research and it was also evident in our research outputs, including the number of peer-reviewed publications. The CARTA experience inculcated a multidisciplinary approach to our research and enabled significant improvement in our organizational, teaching, and leadership skills. All these were achieved through the well-organized structures of CARTA and these have transformed us to change agents who are already taking on research and administrative responsibilities in our various home institutions. Unfortunately, during the long break between the second and the third JAS, there was a gap in communication between CARTA and her fellows, which resulted in some transient loss of focus by a few fellows.Conclusion: The CARTA model which builds the research capacity of doctoral fellows through robust support, including intermittent strategic Joint Advanced Seminars has had effective and transformative impacts on our doctoral odyssey. However, there is a need to maintain the momentum through continuous communication between CARTA and the fellows all through this journey.
- Open Access
- 4 March 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (3) , e1003528
Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study
Background: Cervical cancer screening strategies using visual inspection or cytology may have suboptimal diagnostic accuracy for detection of precancer in women living with HIV (WLHIV). The optimal screen and screen–triage strategy, age to initiate, and frequency of screening for WLHIV remain unclear. This study evaluated the sensitivity, specificity, and positive predictive value of different cervical cancer strategies in WLHIV in Africa. Methods and findings: WLHIV aged 25–50 years attending HIV treatment centres in Burkina Faso (BF) and South Africa (SA) from 5 December 2011 to 30 October 2012 were enrolled in a prospective evaluation study of visual inspection using acetic acid (VIA) or visual inspection using Lugol’s iodine (VILI), high-risk human papillomavirus DNA test (Hybrid Capture 2 [HC2] or careHPV), and cytology for histology-verified high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) at baseline and endline, a median 16 months later. Among 1,238 women (BF: 615; SA: 623), median age was 36 and 34 years (p < 0.001), 28.6% and 49.6% ever had prior cervical cancer screening (p < 0.001), and 69.9% and 64.2% were taking ART at enrolment (p = 0.045) in BF and SA, respectively. CIN2+ prevalence was 5.8% and 22.4% in BF and SA (p < 0.001), respectively. VIA had low sensitivity for CIN2+ (44.7%, 95% confidence interval [CI] 36.9%–52.7%) and CIN3+ (56.1%, 95% CI 43.3%–68.3%) in both countries, with specificity for ≤CIN1 of 78.7% (95% CI 76.0%–81.3%). HC2 had sensitivity of 88.8% (95% CI 82.9%–93.2%) for CIN2+ and 86.4% (95% CI 75.7%–93.6%) for CIN3+. Specificity for ≤CIN1 was 55.4% (95% CI 52.2%–58.6%), and screen positivity was 51.3%. Specificity was higher with a restricted genotype (HPV16/18/31/33/35/45/52/58) approach (73.5%, 95% CI 70.6%–76.2%), with lower screen positivity (33.7%), although there was lower sensitivity for CIN3+ (77.3%, 95% CI 65.3%–86.7%). In BF, HC2 was more sensitive for CIN2+/CIN3+ compared to VIA/VILI (relative sensitivity for CIN2+ = 1.72, 95% CI 1.28–2.32; CIN3+: 1.18, 95% CI 0.94–1.49). Triage of HC2-positive women with VIA/VILI reduced the number of colposcopy referrals, but with loss in sensitivity for CIN2+ (58.1%) but not for CIN3+ (84.6%). In SA, cytology high-grade squamous intraepithelial lesion or greater (HSIL+) had best combination of sensitivity (CIN2+: 70.1%, 95% CI 61.3%–77.9%; CIN3+: 80.8%, 95% CI 67.5%–90.4%) and specificity (81.6%, 95% CI 77.6%–85.1%). HC2 had similar sensitivity for CIN3+ (83.0%, 95% CI 70.2%–91.9%) but lower specificity compared to HSIL+ (42.7%, 95% CI 38.4%–47.1%; relative specificity = 0.57, 95% CI 0.52–0.63), resulting in almost twice as many referrals. Compared to HC2, triage of HC2-positive women with HSIL+ resulted in a 40% reduction in colposcopy referrals but was associated with some loss in sensitivity. CIN2+ incidence over a median 16 months was highest among VIA baseline screen-negative women (2.2%, 95% CI 1.3%–3.7%) and women who were baseline double-negative with HC2 and VIA (2.1%, 95% CI 1.3%–3.5%) and lowest among HC2 baseline screen-negative women (0.5%, 95% CI 0.1%–1.8%). Limitations of our study are that WLHIV included in the study may not reflect a contemporary cohort of WLHIV initiating ART in the universal ART era and that we did not evaluate HPV tests available in study settings today. Conclusions: In this cohort study among WLHIV in Africa, a human papillomavirus (HPV) test targeting 14 high-risk (HR) types had higher sensitivity to detect CIN2+ compared to visual inspection but had low specificity, although a restricted genotype approach targeting 8 HR types decreased the number of unnecessary colposcopy referrals. Cytology HSIL+ had optimal performance for CIN2+/CIN3+ detection in SA. Triage of HPV-positive women with HSIL+ maintained high specificity but with some loss in sensitivity compared to HC2 alone.
- 4 March 2021
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 18 (3) , e1003528
Open AccessDiagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study
Background: Cervical cancer screening strategies using visual inspection or cytology may have suboptimal diagnostic accuracy for detection of precancer in women living with HIV (WLHIV). The optimal screen and screen–triage strategy, age to initiate, and frequency of screening for WLHIV remain unclear. This study evaluated the sensitivity, specificity, and positive predictive value of different cervical cancer strategies in WLHIV in Africa. Methods and findings: WLHIV aged 25–50 years attending HIV treatment centres in Burkina Faso (BF) and South Africa (SA) from 5 December 2011 to 30 October 2012 were enrolled in a prospective evaluation study of visual inspection using acetic acid (VIA) or visual inspection using Lugol’s iodine (VILI), high-risk human papillomavirus DNA test (Hybrid Capture 2 [HC2] or careHPV), and cytology for histology-verified high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) at baseline and endline, a median 16 months later. Among 1,238 women (BF: 615; SA: 623), median age was 36 and 34 years (p < 0.001), 28.6% and 49.6% ever had prior cervical cancer screening (p < 0.001), and 69.9% and 64.2% were taking ART at enrolment (p = 0.045) in BF and SA, respectively. CIN2+ prevalence was 5.8% and 22.4% in BF and SA (p < 0.001), respectively. VIA had low sensitivity for CIN2+ (44.7%, 95% confidence interval [CI] 36.9%–52.7%) and CIN3+ (56.1%, 95% CI 43.3%–68.3%) in both countries, with specificity for ≤CIN1 of 78.7% (95% CI 76.0%–81.3%). HC2 had sensitivity of 88.8% (95% CI 82.9%–93.2%) for CIN2+ and 86.4% (95% CI 75.7%–93.6%) for CIN3+. Specificity for ≤CIN1 was 55.4% (95% CI 52.2%–58.6%), and screen positivity was 51.3%. Specificity was higher with a restricted genotype (HPV16/18/31/33/35/45/52/58) approach (73.5%, 95% CI 70.6%–76.2%), with lower screen positivity (33.7%), although there was lower sensitivity for CIN3+ (77.3%, 95% CI 65.3%–86.7%). In BF, HC2 was more sensitive for CIN2+/CIN3+ compared to VIA/VILI (relative sensitivity for CIN2+ = 1.72, 95% CI 1.28–2.32; CIN3+: 1.18, 95% CI 0.94–1.49). Triage of HC2-positive women with VIA/VILI reduced the number of colposcopy referrals, but with loss in sensitivity for CIN2+ (58.1%) but not for CIN3+ (84.6%). In SA, cytology high-grade squamous intraepithelial lesion or greater (HSIL+) had best combination of sensitivity (CIN2+: 70.1%, 95% CI 61.3%–77.9%; CIN3+: 80.8%, 95% CI 67.5%–90.4%) and specificity (81.6%, 95% CI 77.6%–85.1%). HC2 had similar sensitivity for CIN3+ (83.0%, 95% CI 70.2%–91.9%) but lower specificity compared to HSIL+ (42.7%, 95% CI 38.4%–47.1%; relative specificity = 0.57, 95% CI 0.52–0.63), resulting in almost twice as many referrals. Compared to HC2, triage of HC2-positive women with HSIL+ resulted in a 40% reduction in colposcopy referrals but was associated with some loss in sensitivity. CIN2+ incidence over a median 16 months was highest among VIA baseline screen-negative women (2.2%, 95% CI 1.3%–3.7%) and women who were baseline double-negative with HC2 and VIA (2.1%, 95% CI 1.3%–3.5%) and lowest among HC2 baseline screen-negative women (0.5%, 95% CI 0.1%–1.8%). Limitations of our study are that WLHIV included in the study may not reflect a contemporary cohort of WLHIV initiating ART in the universal ART era and that we did not evaluate HPV tests available in study settings today. Conclusions: In this cohort study among WLHIV in Africa, a human papillomavirus (HPV) test targeting 14 high-risk (HR) types had higher sensitivity to detect CIN2+ compared to visual inspection but had low specificity, although a restricted genotype approach targeting 8 HR types decreased the number of unnecessary colposcopy referrals. Cytology HSIL+ had optimal performance for CIN2+/CIN3+ detection in SA. Triage of HPV-positive women with HSIL+ maintained high specificity but with some loss in sensitivity compared to HC2 alone.
- Open Access
- 14 February 2020
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 84 (2) , 141-148
Human Papillomavirus Seroprevalence and Seroconversion Among Men Living With HIV: Cohort Study in South Africa
Background: Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact. We determined HPV seroprevalence and evaluated factors associated with HPV seroconversion among MLHIV in Johannesburg, South Africa. Methods: We enrolled 304 sexually active MLHIV ≥18 years and collected socio-behavioral data, blood samples (CD4+ counts, HIV-1 plasma viral load [PVL] and HPV serology), genital and anal swabs (HPV DNA and HPV Viral Load [VL]) at enrolment and 6-monthly for up to 18 months. Antibodies to 15 HPV types were measured using HPV pseudovirions. Generalised estimating equations were used to evaluate correlates of HPV seroconversion. Results: Median age at enrolment was 38 years (IQR:22-59), 25% reported >1 sexual partner in the past 3 months and 5% reported ever having sex with other men. Most participants (65%) were on antiretroviral therapy (ART), with median CD4+ count of 445 cells/µL (IQR:328-567). Seroprevalence for any-HPV type was 66% (199/303). Baseline seropositivity for any bivalent (16/18), quadrivalent (6/11/16/18) and nonavalent (6/11/16/18/31/33/45/52/58) vaccine-types were 19%, 37% and 60% respectively. At 18 months, type-specific seroconversion among 59 men whose genital samples were HPV-DNA positive but seronegative for the same type at enrolment was 22% (13/59). Type-specific seroconversion was higher among men with detectable HIV-PVL (adjusted odds-ratio [aOR]=2.78, 95%CI:1.12-6.77) and high HPV-VL (aOR=3.32, 95%CI:1.42-7.74). Conclusion: Seropositivity and exposure to nonavalent HPV types were high among MLHIV. HPV vaccination of boys before they become sexually active could reduce the burden of HPV infection among this at-risk population.
- 14 February 2020
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 84 (2) , 141-148
Open AccessHuman Papillomavirus Seroprevalence and Seroconversion Among Men Living With HIV: Cohort Study in South Africa
Background: Men living with HIV (MLHIV) have a high burden of human papillomavirus (HPV)-related cancer. Understanding serological dynamics of HPV in men can guide decisions on introducing HPV vaccination and monitoring impact. We determined HPV seroprevalence and evaluated factors associated with HPV seroconversion among MLHIV in Johannesburg, South Africa. Methods: We enrolled 304 sexually active MLHIV ≥18 years and collected socio-behavioral data, blood samples (CD4+ counts, HIV-1 plasma viral load [PVL] and HPV serology), genital and anal swabs (HPV DNA and HPV Viral Load [VL]) at enrolment and 6-monthly for up to 18 months. Antibodies to 15 HPV types were measured using HPV pseudovirions. Generalised estimating equations were used to evaluate correlates of HPV seroconversion. Results: Median age at enrolment was 38 years (IQR:22-59), 25% reported >1 sexual partner in the past 3 months and 5% reported ever having sex with other men. Most participants (65%) were on antiretroviral therapy (ART), with median CD4+ count of 445 cells/µL (IQR:328-567). Seroprevalence for any-HPV type was 66% (199/303). Baseline seropositivity for any bivalent (16/18), quadrivalent (6/11/16/18) and nonavalent (6/11/16/18/31/33/45/52/58) vaccine-types were 19%, 37% and 60% respectively. At 18 months, type-specific seroconversion among 59 men whose genital samples were HPV-DNA positive but seronegative for the same type at enrolment was 22% (13/59). Type-specific seroconversion was higher among men with detectable HIV-PVL (adjusted odds-ratio [aOR]=2.78, 95%CI:1.12-6.77) and high HPV-VL (aOR=3.32, 95%CI:1.42-7.74). Conclusion: Seropositivity and exposure to nonavalent HPV types were high among MLHIV. HPV vaccination of boys before they become sexually active could reduce the burden of HPV infection among this at-risk population.